Thomas Zeller, MD, PhD

Interview

Latest Updates on the SPORTS Trial and HEAL Registry

11/14/2024

At the 2024 Amputation Prevention Symposium, interventional angiologist Thomas Zeller, MD, discussed his presentations on the SPORTS Registry and the HEAL study.

At the 2024 Amputation...

11/14/2024

Vascular Disease Management

Atherectomy and DEBs for Native Disease and In-Stent Restenosis in the SFA and Popliteal: Stents Can Be Avoided Completely

01/07/2013

Thomas Zeller , MD, PhD;

DEFINITIVE AR seeks to prove that there is an additional benefit to performing atherectomy prior to the use of a drug-eluting balloon.

DEFINITIVE AR seeks to prove...

01/07/2013

Cath Lab Digest

Conference Coverage

The Role of Lithoplasty in Calcified Lesions: Is There Promise of Improved Results?

04/16/2018

Thomas Zeller , MD, PhD;

Recent data have confirmed that an endovascular-first approach using drug-eluting technologies or endoprostheses is at least non-inferior to bypass surgery even in longer lesions. However, the major drawback of balloon angioplasty, and even...

Recent data have confirmed that...

04/16/2018

Vascular Disease Management

AMP 2023

A Patient-Level Pooled Analysis of DCBs vs BMS for the Treatment of Symptomatic Femoropopliteal Disease

09/11/2023

Thomas Zeller , MD, PhD;

Watch as Dr. Thomas Zeller reviews his presentation on the treatment of symptomatic femoropopliteal disease with drug-coated balloons vs bare-metal stents, which he gave at the Amputation Prevention Symposium in August 2023.

Watch as Dr. Thomas Zeller...

09/11/2023

Vascular Disease Management

AMP 2024

SPORTS: Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs Drug-Coated Balloons in Long SFA Lesions; HEAL Study Update

09/18/2024

Thomas Zeller , MD, PhD;

In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.

In this video, Dr. Thomas Zeller...

09/18/2024

Vascular Disease Management

Original Contribution

Total IN.PACT All-Subjects One-Year Analysis and Standard vs Broader Implications

07/01/2020

Daniel S. Kobe , MD;

Mehdi H. Shishehbor , DO, MPH, PhD;

Peter A. Schneider , MD, FACS;

Thomas Zeller , MD, PhD;

Michael R. Jaff , MD, DO;

Drug-coated balloons (DCBs) have been shown to be superior to percutaneous transluminal angioplasty (PTA) for symptomatic femoropopliteal disease in randomized clinical trials; however, their clinical effectiveness and safety in more complex...

Drug-coated balloons (DCBs) have...

07/01/2020

Journal of Invasive Cardiology

Original Research

Acute Results of Directional Atherectomy for the Treatment of Claudication and Critical Limb Ischemia in the DEFINITIVE LE Study

02/08/2017

Krishna J. Rocha-Singh , MD, FACC;

Lawrence A. Garcia , MD, FACC, FAHA;

James F. McKinsey , MD;

Thomas Zeller , MD, PhD;

Michael R. Jaff , MD, DO;

This study assesses the acute safety of directional atherectomy for endovascular treatment of peripheral arterial disease in infrainguinal arteries.